- The trend backdrop is active with a 25-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
ALTHX
PAR
Week ended 07 Aug 2026
Weekly Investor Report
THX Pharma Société Anonyme · Healthcare · Biotechnology
Latest close
4.58 EUR
6.8%
latest week
Weekly setup
Constructive trend
The weekly trend is active. Price is 38.2% above the Trend Line and sits at 85.6% of its 52-week range. The latest completed week returned 6.8%, after a 22.5% four-week move. The latest news-sentiment score is 50/100.
Setup score
80
out of 100
Latest Close
4.58 EUR
7 Aug 2026
1W Return
6.8%
latest completed week
4W Return
22.5%
short-term follow-through
12W Return
30.7%
quarterly tape
Trend Breadth
88.5%
46 of 52 weeks active
Volume Ratio
2.5x
vs 13-week average
- 2 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
6.8%
Latest completed week; four-week move 22.5%.
Indicator stack
94/91
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 38.2% above the Trend Line and sits at 85.6% of its 52-week range. The latest completed week returned 6.8%, after a 22.5% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.7612-week average 0.76
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.76Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 22.5% over four weeks, 30.7% over 12 weeks, and 108.2% over one year. The current trend has remained active for 25 consecutive weeks.
Performance by holding period
Active trend streak25 weeks
Active weeks in one year46
Trend breadth88.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.70Latest activity-pressure read.
Pressure change360.3%Four-week change in activity pressure.
Leadership50.15Latest relative-leadership reading.
RS change42.0%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-10.2%Distance below the 52-week high.
13-week volatility8.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2612 weeks finished lower.
Best week+92.5%Week of 13 Feb.
Worst week-15.8%Week of 5 Jun.
Latest week+6.8%Week of 7 Aug.
Shape of recent returns
Strong gains8
Modest gains6
Flat weeks0
Modest losses7
Sharp losses5
Recent vol8.4%13-week weekly-return volatility.
Base vol16.1%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew11.1% / -7.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorFR Healthcare
4-week rank4 / 76
Group average0.7%
Trend breadth26.3%
Trend26.3%active weekly trend signals
MD40.8%positive activity pressure
RS19.7%positive relative leadership
Four-week leaders
IndustryFR Biotechnology
4-week rank3 / 33
Group average4.5%
Trend breadth27.3%
Trend27.3%active weekly trend signals
MD36.4%positive activity pressure
RS21.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape78/100
Trend, activity pressure, participation, and risk combine to a 78/100 tape read.
Indicator analysis68/100Latest 12-week confirmation: trend 12/12, activity pressure 3/12, relative leadership 12/12.
Activity pressure 0.76; 2 reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
THX Pharma Société Anonyme (ALTHX.PA) stock price, news, quote and history Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 4.58 EUR | 6.8% | 3.31 EUR | 1.53 EUR | 0.70 | 50.15 | 872.0K | On |
| 31 Jul 2026 | 4.29 EUR | 14.1% | 3.23 EUR | 1.51 EUR | 0.39 | 45.97 | 802.2K | On |
| 24 Jul 2026 | 3.76 EUR | 1.8% | 3.16 EUR | 1.49 EUR | 0.12 | 31.11 | 221.9K | On |
| 17 Jul 2026 | 3.69 EUR | -1.2% | 3.10 EUR | 1.48 EUR | -0.13 | 31.32 | 510.2K | On |
| 10 Jul 2026 | 3.74 EUR | 1.6% | 3.05 EUR | 1.46 EUR | -0.27 | 35.31 | 312.6K | On |
| 3 Jul 2026 | 3.68 EUR | 16.8% | 3.00 EUR | 1.44 EUR | -0.54 | 32.77 | 105.3K | On |
| 26 Jun 2026 | 3.15 EUR | -8.4% | 2.94 EUR | 1.43 EUR | -0.76 | 17.25 | 75.5K | On |
| 19 Jun 2026 | 3.44 EUR | 7.8% | 2.89 EUR | 1.42 EUR | -0.38 | 29.42 | 93.8K | On |
| 12 Jun 2026 | 3.19 EUR | 1.3% | 2.83 EUR | 1.41 EUR | -0.43 | 23.33 | 19.9K | On |
| 5 Jun 2026 | 3.15 EUR | -15.8% | 2.79 EUR | 1.41 EUR | -0.20 | 25.83 | 74.6K | On |
| 29 May 2026 | 3.74 EUR | 8.1% | 2.75 EUR | 1.40 EUR | -0.01 | 52.56 | 897.1K | On |
| 22 May 2026 | 3.46 EUR | -1.3% | 2.69 EUR | 1.38 EUR | -0.12 | 45.38 | 248.7K | On |
| 15 May 2026 | 3.50 EUR | 5.4% | 2.64 EUR | 1.37 EUR | 0.14 | 53.25 | 348.7K | On |
| 8 May 2026 | 3.33 EUR | -1.6% | 2.61 EUR | 1.36 EUR | 0.28 | 45.31 | 290.3K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.